IBIO

Ibio

• Seeking Alpha·1d ago

  Ocugen, Assertio among healthcare stocks set to join Russell Microcap; Definium Therapeutics, Tvardi Therapeutics to exit

• TipRanks·05/16 14:36

  LifeSci Capital Remains a Buy on Ibio (IBIO)

• TipRanks·05/15 15:28

  Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)

• PUBT·05/15 11:02

  iBio files Form 3 as director Elizabeth Stoner reports no beneficial ownership

• TipRanks·05/14 13:36

  Oppenheimer Reaffirms Their Buy Rating on Ibio (IBIO)

• TipRanks·05/14 06:10

  Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH) and Ibio (IBIO)

• TipRanks·05/13 13:30

  Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)

• Reuters·05/12 21:43

  BRIEF-Ibio Reports Q3 Fiscal Year 2026 Financial Results And Provides Corporate Update

• TipRanks·05/12 21:36

  iBio reports Q3 EPS (7c), consensus (6c)

• Benzinga·05/12 21:07

  iBio Q3 EPS $(0.07) Misses $(0.06) Estimate

• PUBT·05/12 20:20

  iBio wins Australian clearance to start Phase 1 trial of obesity drug IBIO-600

• Dow Jones·05/12 20:19

  *IBio Extends Cash Runway Into 4Q of Fiscal Yr 2028

• Reuters·05/12 20:05

  IBIO INC: QTRLY LOSS PER SHARE $-0.07

• Dow Jones·05/12 20:05

  Press Release: iBio Reports Q3 Fiscal Year 2026 -2-

• Dow Jones·05/12 20:05

  Press Release: iBio Reports Q3 Fiscal Year 2026 Financial Results and Provides Corporate Update